177 related articles for article (PubMed ID: 3840228)
1. Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism.
LoCascio V; Adami S; Galvanini G; Ferrari M; Cominacini L; Tartarotti D
N Engl J Med; 1985 Oct; 313(18):1123-5. PubMed ID: 3840228
[TBL] [Abstract][Full Text] [Related]
2. The role of insulin in the stimulation of renal 1,25-dihydroxyvitamin D synthesis by parathyroid hormone in rats.
Ikeda K; Matsumoto T; Morita K; Yamato H; Takahashi H; Ezawa I; Ogata E
Endocrinology; 1987 Nov; 121(5):1721-6. PubMed ID: 3311717
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
Gonzalez-Villapando C; Porath A; Berelowitz M; Marshall L; Favus MJ
J Clin Endocrinol Metab; 1980 Nov; 51(5):1180-3. PubMed ID: 6893459
[TBL] [Abstract][Full Text] [Related]
5. Blood Ca2+ modulates responsiveness of renal 25(OH)D3-1 alpha-hydroxylase to PTH in rats.
Matsumoto T; Ikeda K; Morita K; Fukumoto S; Takahashi H; Ogata E
Am J Physiol; 1987 Nov; 253(5 Pt 1):E503-7. PubMed ID: 2825531
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity.
Lyles KW; Drezner MK
J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432
[TBL] [Abstract][Full Text] [Related]
7. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
Portale AA; Booth BE; Halloran BP; Morris RC
J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
[TBL] [Abstract][Full Text] [Related]
8. Does the plasma concentration of 25-hydroxyvitamin D determine the level of 1,25-dihydroxyvitamin D in primary hyperparathyroidism?
Frølich A; Storm T; Thode J
Miner Electrolyte Metab; 1996; 22(4):203-6. PubMed ID: 8807622
[TBL] [Abstract][Full Text] [Related]
9. Interrelationships between the key elements of the vitamin D endocrine system: 25-OH-D3-1-hydroxylase, serum calcium and phosphorus levels, intestinal 1,25(OH)2D3, and intestinal calcium binding protein.
Norman AW; Friedlander EJ; Henry H
Adv Exp Med Biol; 1977; 81():211-31. PubMed ID: 331899
[No Abstract] [Full Text] [Related]
10. Regulation and its refractoriness of 25-hydroxyvitamin D3 metabolism in vitamin D deficiency.
Takahashi N; Miyaura C; Horiuchi N; Suda T
J Nutr Sci Vitaminol (Tokyo); 1981; 27(5):429-37. PubMed ID: 7320768
[TBL] [Abstract][Full Text] [Related]
11. Primary hyperparathyroidism with low serum 1,25-dihydroxyvitamin D levels.
Wortsman J; Haddad JG; Posillico JT; Brown EM
J Clin Endocrinol Metab; 1986 Jun; 62(6):1305-8. PubMed ID: 3754562
[TBL] [Abstract][Full Text] [Related]
12. Lack of effect of 24,25-dihydroxyvitamin D3 administration on parameters of calcium metabolism.
Harvey JA; Zerwekh JE; Sakhaee K; Pak CY
J Clin Endocrinol Metab; 1989 Aug; 69(2):467-9. PubMed ID: 2787802
[TBL] [Abstract][Full Text] [Related]
13. Main endocrine modulators of vitamin D hydroxylases in human pathophysiology.
Caniggia A; Lorè F; di Cairano G; Nuti R
J Steroid Biochem; 1987; 27(4-6):815-24. PubMed ID: 3320561
[TBL] [Abstract][Full Text] [Related]
14. Effect of the X-linked Hyp mutation and vitamin D status on induction of renal 25-hydroxyvitamin D3-24-hydroxylase.
Tenenhouse HS; Jones G
Endocrinology; 1987 Feb; 120(2):609-16. PubMed ID: 3803293
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in pediatric metabolic bone disease: the consequences of altered phosphate homeostasis in renal insufficiency and hypophosphatemic vitamin D-resistant rickets.
Pettifor JM
Bone Miner; 1990 Jun; 9(3):199-214. PubMed ID: 2163713
[TBL] [Abstract][Full Text] [Related]
16. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis.
Brandi L; Daugaard H; Tvedegaard E; Storm T; Olgaard K
Nephron; 1989; 53(3):194-200. PubMed ID: 2797340
[TBL] [Abstract][Full Text] [Related]
18. Effect of parathyroid hormone on cAMP and 1,25-dihydroxyvitamin D formation and renal handling of phosphate in vitamin D-dependent rickets.
Aarskog D; Aksnes L; Markestad T
Pediatrics; 1983 Jan; 71(1):59-63. PubMed ID: 6294581
[TBL] [Abstract][Full Text] [Related]
19. Abnormal parathyroid hormone stimulation of 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the hypophosphatemic mouse. Evidence for a generalized defect of vitamin D metabolism.
Nesbitt T; Drezner MK; Lobaugh B
J Clin Invest; 1986 Jan; 77(1):181-7. PubMed ID: 3753708
[TBL] [Abstract][Full Text] [Related]
20. The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism.
Gray RW; Wilz DR; Caldas AE; Lemann J
J Clin Endocrinol Metab; 1977 Aug; 45(2):299-306. PubMed ID: 885994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
